U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Ciduvectamig
INN  
Official Name English
Immunoglobulin G4 [228-proline,234-alanine,235-alanine,405-leucine,409-lysine], anti-(human CD3 antigen ε-chain) (human monoclonal CD3B376 γ4-chain), disulfide with human monoclonal CD3B376 λ-chain, (226.fwdarw.224′),(229.fwdarw.227′)-bis(disulfid
Common Name English
Ciduvectamig (immunoglobulin G4-kappa/lambda2, anti-[Homo sapiens TMEFF2 (transmembrane protein with EGF like and two follistatin like domains 2, cancer/testis antigen family 120 member 2, CT120.2, tomoréguline)] and anti-[Homo sapiens CD3E (CD3e, CD3 e
Common Name English
ciduvectamig [INN]
Common Name English
Code System Code Type Description
FDA UNII
VJH7ED7HR8
Created by admin on Sat Dec 16 18:24:28 GMT 2023 , Edited by admin on Sat Dec 16 18:24:28 GMT 2023
PRIMARY
CAS
2412587-62-1
Created by admin on Sat Dec 16 18:24:28 GMT 2023 , Edited by admin on Sat Dec 16 18:24:28 GMT 2023
PRIMARY
INN
12199
Created by admin on Sat Dec 16 18:24:28 GMT 2023 , Edited by admin on Sat Dec 16 18:24:28 GMT 2023
PRIMARY
ACTIVE MOIETY
Ciduvectamig
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966